These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3263941)

  • 1. T-cell-derived factor B151-TRF1/IL-5 activates blastoid cells among unprimed B cells to induce a polyclonal differentiation into immunoglobulin M-secreting cells.
    Murakami S; Ono S; Harada N; Hara Y; Katoh Y; Dobashi K; Takatsu K; Hamaoka T
    Immunology; 1988 Oct; 65(2):221-8. PubMed ID: 3263941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levels.
    Ishihara K; Ono S; Takahama Y; Hirayama F; Hirano H; Itoh K; Dobashi K; Murakami S; Katoh Y; Yamaguchi M
    Immunology; 1989 Oct; 68(2):154-62. PubMed ID: 2553585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two distinct factors, B151-TRF1 and B151-TRF2, inducing differentiation of activated B cells and small resting B cells into antibody-producing cells.
    Ono S; Hayashi S; Takahama Y; Dobashi K; Katoh Y; Nakanishi K; Paul WE; Hamaoka T
    J Immunol; 1986 Jul; 137(1):187-96. PubMed ID: 3519774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal B-cell activation by a B-cell differentiation factor B151-TRF2. IV. B151-TRF2-responsive F1 B cells consist of two separate populations capable of recognizing only one of the parental I-A products expressed on B cells.
    Takaháma Y; Ono S; Glimcher LH; Hamaoka T
    J Mol Cell Immunol; 1987; 3(3):177-94. PubMed ID: 3509923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal B cell activation by B cell differentiation factor B151-TRF2. I. Involvement of self-Ia recognition process mediated by B cells.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1986 Aug; 137(4):1149-56. PubMed ID: 3090140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on B cell reactivities in two X-linked immunodeficient mice to the B cell-stimulating factors.
    Hayashi S; Tomita S; Kanatani T; Takatsu K; Ono S; Hamaoka T
    Lymphokine Res; 1986; 5(3):229-38. PubMed ID: 3489143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. II. Evidence for interaction of B151-TRF2 with glycoprotein on B cell membrane via recognition of terminal N-acetyl-D-glucosamine residue(s).
    Katoh Y; Ono S; Takahama Y; Miyake K; Hamaoka T
    J Immunol; 1986 Nov; 137(9):2871-7. PubMed ID: 3489778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ia-restricted B-B cell interaction. I. The MHC haplotype of bone marrow cells present during B cell ontogeny dictates the self-recognition specificity of B cells in the polyclonal B cell activation by a B cell differentiation factor, B151-TRF2.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1987 Nov; 139(10):3213-23. PubMed ID: 3316381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for existence of two distinct TNP-Ficoll-responsive B cell subpopulations preferentially reactive either to a T cell-replacing factor (B151-TRF) or to a signal from accessory cells.
    Hayashi S; Ono S; Miyake K; Tsukada S; Takatsu K; Hamaoka T
    J Immunol; 1986 Mar; 136(6):2069-75. PubMed ID: 3485139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and -stimulating activity.
    Takahama Y; Ono S; Hara Y; Hayashi S; Dobashi K; Hamaoka T
    J Immunol; 1985 Oct; 135(4):2534-40. PubMed ID: 3897376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both B151-T cell replacing factor 1 and IL-5 regulate Ig secretion and IL-2 receptor expression on a cloned B lymphoma line.
    Nakanishi K; Yoshimoto T; Katoh Y; Ono S; Matsui K; Hiroishi K; Noma T; Honjo T; Takatsu K; Higashino K
    J Immunol; 1988 Feb; 140(4):1168-74. PubMed ID: 3125248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.
    Koyama N; Harada N; Takahashi T; Mita S; Okamura H; Tominaga A; Takatsu K
    Immunology; 1988 Feb; 63(2):277-83. PubMed ID: 3280472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors.
    Layton JE; Krammer PH; Hamaoka T; Uhr JW; Vitetta ES
    J Mol Cell Immunol; 1985; 2(3):155-67. PubMed ID: 2978227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation.
    Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
    Eur J Immunol; 1989 Dec; 19(12):2227-35. PubMed ID: 2558020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM.
    Bertolini JN; Sanderson CJ; Benson EM
    Eur J Immunol; 1993 Feb; 23(2):398-402. PubMed ID: 8436175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM.
    Defrance T; Vanbervliet B; Pène J; Banchereau J
    J Immunol; 1988 Sep; 141(6):2000-5. PubMed ID: 2971718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell replacing factor/interleukin 5 induces not only B-cell growth and differentiation, but also increased expression of interleukin 2 receptor on activated B-cells.
    Harada N; Matsumoto M; Koyama N; Shimizu A; Honjo T; Tominaga A; Takatsu K
    Immunol Lett; 1987 Jul; 15(3):205-15. PubMed ID: 3117678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells.
    Punnonen J; de Vries JE
    J Immunol; 1994 Feb; 152(3):1094-102. PubMed ID: 7507958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.